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Abstract
Objective: Cataplexy is a complicated and dynamic process in narcolepsy type
1 (NT1) patients. This study aimed to clarify the distinct stages during a cata-
plectic attack and identify the changes of the primary motor cortex (PMC)
excitability during these stages. Methods: Thirty-five patients with NT1 and 29
healthy controls were recruited to this study. Cataplectic stages were distin-
guished from a cataplectic attack by video-polysomnogram monitoring. Tran-
scranial magnetic stimulation motor-evoked potential (TMS-MEP) was
performed to measure the excitability of PMC during quiet wakefulness, laugh-
ter without cataplexy, and each cataplectic stage. Results: Based on the video
and electromyogram observations, a typical cataplectic attack (CA) process is
divided into four stages: triggering (CA1), resisting (CA2), atonic (CA3), and
recovering stages (CA4). Compared with healthy controls, NT1 patients showed
significantly decreased intracortical facilitation during quiet wakefulness. During
the laughter stage, both patients and controls showed increased MEP amplitude
compared with quiet wakefulness. The MEP amplitude significantly increased
even higher in CA1 and 2, and then dramatically decreased in CA3 accompa-
nied with prolonged MEP latency compared with the laughter stage and quiet
wakefulness. The MEP amplitude and latency gradually recovered during CA4.
Interpretation: This study identifies four stages during cataplectic attack and
reveals the existence of a resisting stage that might change the process of cata-
plexy. The fluctuation of MEP amplitude and MEP latency shows a potential
participation of PMC and motor control pathway during cataplexy, and the
increased MEP amplitude during CA1 and 2 strongly implies a compensatory
mechanism in motor control that may resist or avoid cataplectic attack.
Introduction
In narcolepsy type 1 (NT1), cataplexy is the most distinc-
tive clinical manifestation, which is characterized by com-
plete voluntary muscle atonia with full conscious
awareness.1 A typical cataplexy is most often triggered by
strong emotions (such as laughter, anger, or being star-
tled) with paralysis lasting for seconds to minutes, after
which strength is restored without any sequelae.2,3 How-
ever, cataplexy is not a simple and stable myoelectric
inhibition status. Several studies have reported dynamic
behavioral features during cataplectic attack, such as
stereotyped motor behaviors (facial movements and body
swaying),2,4,5 were accompanied with repeated brief
enhanced myoelectric activity during initial cataplexy.6,7
Therefore, it is very important to analyze the dynamic
process of cataplectic attack.
Since active movement is mainly controlled by the pri-
mary motor cortex (PMC) during wakefulness,8,9 it is
important to understand how the PMC and motor conduc-
tion system work during the cataplectic process. Transcranial
magnetic stimulation motor-evoked potentials (TMS-MEP)
are a non-invasive measurement that would directly activate
cortical interneurons as well as pyramidal neurons,10,11 and
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reflect the functional integrity of the whole motor conduc-
tion pathway.12 To our knowledge, there have been only two
single-case reports that have observed the motor control sys-
tem alterations by using TMS-MEP during cataplexy, but
the findings were contradictory.13,14 Considering the compli-
cated cataplexy process, it is essential to investigate the
changes of motor control system during the cataplectic
attack by a larger scale study.
To address these issues, we applied a video-polysomno-
gram monitoring to objectively classify different stages of
cataplectic attack which were triggered by emotional stim-
uli at sleep center. Further, by using TMS-MEP, we aimed
to determine the different characteristics of PMC
excitability and the conductive functions of the pyramidal
tract during the quiet wakefulness (QW) state, laughter
without cataplexy state, and each cataplectic stage in
order to verify the dynamic fluctuation of the PMC
excitability and reveal the underline mechanism of PMC
activity against the cataplectic attack.
Methods
Subjects
A total of 35 patients meeting the diagnostic criteria for
NT1 by the International Classification of Sleep Disorders,
3rd Edition (ICSD-3) and having typical and frequent cata-
plectic attack (more than once a month) were recruited in
the sleep center at the Changzheng Hospital, Shanghai,
China, from August 2012 to December 2017. Twenty-nine
healthy volunteers from community-based sample were
recruited as controls. The exclusion criteria for both
patients and controls included: (1) obstructive sleep apnea
syndrome (AHI > 10/h); (2) idiopathic hypersomnia; (3) a
history of sleep restriction/deprivation; (4) shift work or jet
lag; (5) drug abuse; (6) other neurological, psychiatric, or
chronic medical conditions (such as diabetes or thyroid
disease); and (7) taking psychotropic medications (includ-
ing anticataplectic drugs) in the previous 3 weeks.
All subjects aged above 18 years gave written informed
consent. For those subjects aged less than 18 years old,
their parents gave written consents and the subjects gave
written assents. The study was approved by the ethics
committee of the Changzheng Hospital.
Study protocol
This study contained two sections. Section 1 was a case-
control design. We compared TMS-MEP between NT1
patients and controls during quiet wakefulness and laugh-
ter. Section 2 was a within-subject design. Cataplectic epi-
sodes of NT1 patients were segmented according to the
video-polysomnogram (v-PSG), and then MEP amplitudes
were measured during cataplexy for further segmental
analysis.
TMS-MEP
Transcranial magnetic stimulation motor-evoked potential
was performed at the Shanghai Mental Health Center,
using a MagPro X100 magnetic stimulator and a MC-B70
butterfly coil (Medtronic,Denmark). Muscle responses
were recorded in abductor pollicis brevis. Electromyo-
grams (EMG) were obtained via Ag-AgCl surface elec-
trodes and recorded by a key point myoelectricity-evoked
potential apparatus (Medtronic, Denmark).
The following TMS measurements were evaluated by an
experienced TMS technician: Rest motor threshold (RMT)
was defined as the minimum stimulus intensity that TMS
evokes at least five positive MEPs (amplitudes >50 lV) out
of ten trials; 1 mV motor threshold (1 mV MT) was a
higher stimulus intensity that could evoke not less than five
MEPs (amplitudes >1 mV) in ten trials; Cortical silent per-
iod (CSP) was conducted in the voluntary muscle contrac-
tion (20% of maximum contraction) under the intensity of
120% RMT, CSP was defined as the duration EMG silence.
Intracortical facilitation (ICF) and short latency intracorti-
cal inhibition (SICI) were evoked by a paired-pulse stimu-
lation which involved a conditioning stimulus (CS)
followed by a test stimulus (TS). CS was a subthreshold
stimulus (80% RMT) while TS was a suprathreshold (1 mV
MT). ICF was induced at an inter-stimulus interval (ISI) of
10 msec and SICI of 3 msec. Average paired-pulse stimula-
tion MEP amplitudes were compared with those produced
by the TS alone (1 mV MT MEP) to assess intra-cortical
facilitation and inhibition.
Case-control design
Narcolepsy type 1 patients and controls were instructed
to sit up straight in chair, a brief nap would be arranged
for sleepy subjects (Stanford Sleepiness Scale score > 215).
MEP was recorded in dominant hands and stimulated by
a coil located on the contralateral motor cortex. We mea-
sured 1 mV MT, RMT, CSP, ICF, and SICI successively
during the QW state. Then all subjects were scheduled to
watch humorous film clips. Typical laughter episodes
(without cataplexy) were captured and measured under
1 mV MT stimulation.
Within-subject design
Video-EMG and cataplectic stages
All NT1 patients were recruited for a video-PSG and trig-
ger-test in a soundproof room. Video-PSG monitoring
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(NIHON KOHDEN Inc, Polysmith 7.0 sleep analysis sys-
tem) including electroencephalogram (EEG) derivations
F3/C3/O1-A2 and F4/C4/O2-A1 (International 10–20 sys-
tem), bilateral electro-oculogram (EOG), submental and
anterior tibialis electromyograms (EMG), and 2-lead elec-
trocardiogram (ECG). A three-minute quiet state with
eyes closed was recorded as the QW stage. Then, the
patients were triggered into cataplexy using specific stim-
ulated scenarios (humorous and comedy videos, aerobic
exercise, recollection of a happy or frightening memory,
etc.). The recordings of cataplectic attack were simultane-
ously analyzed by two independent experienced sleep
physicians to reach consensus on the confirmation of cat-
aplectic attack.
TMS-MEP under cataplectic stages
All NT1 patients were triggered and were under the close
observation of two staff members. MEP would be mea-
sured under 1 mV MT as soon as any appearance of cata-
plectic behaviors. Research staff helped maintaining the
standard MEP test position in case of excessive move-
ments. As CSP, ICF, and SICI were time consuming, we
only measured them during long cataplectic attacks.
Statistical analysis
Statistical analyses were performed with SPSS 22.0. For a
two-group comparison, continuous variables were com-
pared by t-test or Mann–Whitney U test while categorical
variables were compared by using Pearson’s chi-square
test or Fisher’s exact test, where appropriate. To minimize
the individual and intra-group differences, we used the
magnitude of the MEP amplitude and of MEP latency
rather than absolute value of these variables to run within
individual comparisons between stages in section 2. The
paired sample t-test was conducted for within-individual
comparisons. For viewing multiple comparisons, a Bon-
ferroni adjustment was used to control for false positives,
where a P < 0.015 was considered statistically significant.
P < 0.05 were taken as the statistically significant thresh-
old for all other tests.
Results
Thirty-five NT1 patients (23 males) and twenty-nine con-
trols (21 males) were included in this study (Fig. 1).
Among all, 28 patients were newly diagnosed and drug-
na€ıve, seven patients had withdrawn drugs for at least
3 weeks prior. CSF Hypocretin-1 was tested in 11 patients
and all of them showed significantly decreased concentra-
tion (Table 1, Table S1).
During quiet wakefulness and laughter
state
During quiet wakefulness, ICF significantly decreased in
NT1 patients (109.8  54.4 vs. 184.7  73.2%,
P < 0.001] compared with 29 age-matched healthy con-
trols. While 1 mV MT (46.6  7.7 vs. 46.1  5.6%,
Figure 1. Participant inclusion flowchart. This study contains two sections with two study designs: case-control design and within-subject design.
NT1, narcolepsy type 1 patients; CTL, controls.
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P = 0.77), RMT (35.1  5.5 vs. 37.2  5.6, P = 0.15),
CSP (70.0  25.9 vs. 74.5  33.8, P = 0.60), and SICI
[41.3 (34.0, 57.1) vs. 41.9 (24.3, 68.9), P = 0.96] did not
differ between groups (Table 2).
Laughter episodes were recorded in 10 NT1 patients
and 12 age-matched healthy controls. MEP amplitude
notably increased in both patients [0.91 (0.76, 1.3) vs. 1.7
(1.3, 2.0) mV, P = 0.005] and controls [0.99 (0.78, 1.24)
vs. 2.3 (2.0, 3.3) mV, P = 0.005], but the magnitude of
MEP amplitude was much lower in NT1 patients
(1.8  0.62 vs 2.5  0.35, P = 0.008) (Table 2).
During cataplectic stages
Cataplexy stages based on the behavioral-EMG
activity
Fourteen patients were successfully triggered under the
video-PSG monitoring. We proposed a modified cata-
plexy staging focusing on the behavioral and EMG fea-
tures: triggering (CA1), resisting (CA2), atonic (CA3),
and recovering (CA4) stages. Ten patients experienced
four stages with complete cataplectic episodes, while the
other four patients showed partial cataplexy (without
classical CA3). A typical complete cataplectic attack with
four stages is shown in Figure 2. Behavioral and EMG
characteristics of each stage are concluded and shown as
follows.
CA1 - Triggering stage. In this stage, a cessation of pre-
vious behaviors was observed, such as ceasing to move or
laugh, fixed or glazed eyes, drooping eyelids or a stiff
facial expression. This stage is transient and shows no
obvious or slight alterations of muscle tension.
CA2 - Resisting stage. After triggering, patients started
twitching, flapping up and down of their body, and had
postural instability. The complex behaviors may be during
both the conscious (e.g., shaking and raising the head,
supporting the body by hands) and unconscious state
(e.g., flapped up and down motion of their body). The
EMG showed paroxysmal enhanced EMG activities, which
may occur against a background of muscle atonia.
CA3 - Atonic stage. Loss of muscle tone gradually
extended to the neck, shoulders, trunk or knees, ending
with partial or global paralysis. Typically, this stage shows
that the EMG is silent, with occasional eye movement
bursts.
CA4 - Recovering stage. Postural tone recovers from
CA3 gradually and normal motor control is restored.
Fluctuations of TMS-MEP during cataplectic stages
Considering the brief duration and quick conversion of
CA1 stage, we took the data of the CA1 and 2 stages
together for analyses. CA3 and CA4 stages were success-
fully recorded in 12 patients, but typical CA1 and 2 stage
episodes were only recorded in eight patients because cat-
aplexy could not be triggered in four patients in situ and
the CA1 and 2 data were missed.
The MEP amplitudes between the QW and the cata-
plectic stages showed remarkable fluctuations. Figure 3A,
B shows the typical MEP fluctuations of the complete
and partial cataplexy in two patients. Compared with the
Table 1. Clinical characteristics and sleep study results of experimen-
tal groups.
Controls (N = 29) NC patients (N = 35)
Age (yr) 24.9  14.0 23.2  17.4
Sex (M/F) 19/10 23/12
BMI (Kg/m2) 20.7  3.3 26.7  4.4
Duration of illness (yr) N.A. 3.82  2.5
ESS score 8.1  3.7 16.3  2.7
Sleep paralysis 1/29 14/35
Treatment N.A. 7/35
Nocturnal SE (%) N.A. 81.8  8.9
No. of SOREMPs N.A. 3.3  0.8
CSF hypocretin-11 N.A. 26.5  28.1
N.A., not applicable.
1Results were based on 11 patients.
Table 2. TMS-MEP parameters during quiet wakefulness and laughter
states.
Controls NT1 patients P
QW state
Number of subjects 29 291
Sex (M/F) 19/10 21/8 0.57
Median age (years) 17 (16, 33.5) 15 (13, 34) 0.31
TMS parameters
1 mV MT (%) 46.1  5.6 46.6  7.7 0.77
RMT (%) 37.2  5.6 35.1  5.5 0.15
CSP (msec) 74.5  33.8 70.0  25.9 0.60
ICF (%) 184.7  73.2 109.8  54.4 <0.001
SICI (%) 41.9 (24.3, 68.9) 41.3 (34.0, 57.1) 0.96
LA state
Number of subjects 10 12
Sex (M/F) 8/2 9/3 0.65
Median age (years) 14 (14, 29.8) 14 (12.3, 23.5) 0.46
TMS parameters
QW MEP amp (mV) 0.99 (0.78, 1.24) 0.91(0.76, 1.3) 0.67
LA MEP amp (mV) 2.3 (2.0, 3.3) 1.7 (1.3, 2.0) 0.04
Magnitude of amp 2.5  0.35 1.8  0.62 0.008
TMS-MEP, Transcranial magnetic stimulation motor-evoked potential;
NT1, narcolepsy type 1; QW, quiet wakefulness; 1 mV MT, 1 mV
motor threshold; RMT, rest motor threshold; CSP, cortical silent per-
iod; ICF, intracortical facilitation; SICI, short latency intracortical inhibi-
tion; LA, laughter.
1Among 29 patients, 23 patients had CSP, ICF, and SICI measurements.
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QW, the magnitude significantly increased during the
CA1 and 2 stages (2.7  0.86 vs. 1, P < 0.001), then
reduced below baseline in the CA3 stage (0.37  0.17 vs.
1, P = 0.004), and gradually recovered during the CA4
stage (1.1  0.36 vs. 1, P = 0.235); Particularly, the
increase during the CA1 and 2 stage was remarkable, even
higher than the laughter stage (2.7  0.86 vs. 1.8  0.62,
P = 0.02) (Fig. 4A).
The MEP latency during the CA3 stage was notably
prolonged during the cataplectic attack (CA3 vs. QW:
23.7  1.1 vs. 21.0  1.5 msec,P < 0.001, Fig. 3C), and
the magnitude fluctuation of MEP latency was as shown
in Figure 4B. Notably, an increase of 6 msec during the
CA3 stage was recorded from a new-onset, middle-aged
male patient (No.18), with a cataplectic frequency that
varied from several to dozens of times a day.
Four patients, who experienced long duration attacks,
had further examinations of the ICF, SICI, and CSP dur-
ing the CA3 stage. Compared with the QW, notable pro-
longed CSP duration (123.7  9.9 vs. 72.0  4.2 msec,
P = 0.04) was observed in patients. However, the attenua-
tion of ICF (73.0  38.5 vs. 95.8  45.0%, P = 0.36) and
the increase of SICI (26.3  12.9 vs. 49.7  11.8%, P =
0.09) were not significant due to the small sample size.
Discussion
This is the first study to reveal the dynamic changes of
PMC excitability by TMS-MEP during four modified
cataplectic stages in NT1 patients based on the behaviors
and muscular features. Besides the decreased intracortical
facilitation in PMC during QW, we discovered dynamic
changes of PMC in patients: the MEP amplitude
increased during laughter, and even higher during CA1
and 2, then significantly decreased with obvious pro-
longed latency during CA3; MEP amplitude was gradually
restored in CA4. The fluctuations of excitability in the
PMC and the motor conduction pathway, as continuously
detected by TMS-MEP, reveal comprehensive interbrain
coordination during the cataplectic process.
Four-stage cataplectic attack
Cataplexy was first segmented according to EEG charac-
teristics in animal studies, from a stage resembling wake-
fulness to a REM-like stage, and a final stage dominated
by mixed amplitude and frequency activity.16,17 Then a
scholar focused on the behavioral features of cataplectic
episodes in one NT1 patient and identified three phases
of cataplexy — namely, initial phase, falling phase, and
atonic phase.6 In addition, autonomic functions also indi-
cate a segmental cataplexy, for example, heart rate signifi-
cantly increased prior to the muscle atonia of cataplexy,
and then decreased along with increased muscle sympa-
thetic nervous activity, systolic blood pressure and
decreased skin sympathetic reaction.18,19
Our study segmented cataplexy based on a larger sam-
ple size, which included different phenotypes, triggers and
Figure 2. Video polysomnogram-monitoring during a typical complete cataplectic attack (Patient No. 8), exhibiting four stages: triggering,
resisting, atonic, and recovering. Chin EMG (yellow) showed paroxysmal enhanced activity synchronized with twitching and postural instability
during CA2, while gradually recovered during CA4.
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onset age. Triggering stage (CA1) is more like a state that
converts into cataplexy, which is consistent with the
description by Wilson4 that patient said “it’s coming on
now” in a slightly indistinct voice just before the cataplec-
tic attack. Resisting stage (CA2) resembled previous initial
and falling stage, apposite to the “enacted intentional
movements in response to the segmental postural
lapses”.7 Patients fight against the inner uncontrolled
change and display complex movement5. At the same
time, EMG shows paroxysmal enhanced activity. So CA2
is regarded as a “fighting process”. Atonia stage (CA3) is
the most distinct stage with postural collapse and atonia/
lower muscle tone and is the state of most concern.
Recovering stage (CA4) is usually neglected; it indicates a
Figure 3. (A) Fluctuations of MEP amplitude during complete cataplexy (patient No.10) and (B) partial cataplexy (patient No.14) under the
stimulus intensity of 1 mV MT. (C) MEP latency immediately prolonged in CA3 compared with QW, then shortened back to normal level during
CA4. QW, quiet wakefulness; MEP, Motor evoked potentials.
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Figure 4. (A) In patients with NT1, Magnitudes of MEP amplitude increased during LA, even higher during CA1 and2, then dramatically
decreased during CA3, and recovered gradually during CA4. (B) Magnitudes of MEP latency only significantly prolonged during CA3 compared
with QW. * indicate P < 0.05 and ** indicate P < 0.001. Error bars indicate SD. NT1, narcolepsy type 1; CTL, controls; QW, quiet wakefulness;
LA, laughter; MEP, Motor evoked potentials; MT, motor threshold.
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gradual recovery from atonia to normal muscle tone, also
accompanied with a gradual recovery of heart rate and
muscle sympathetic nervous activity.15 However, in fact,
it is very hard to distinguish CA1 from CA2 using avail-
able biomarkers, and sometimes CA2 and CA3 are mixed
by persistent resistance and abolishment due to the efforts
of the patients’ motivation. In general, the four stages we
proposed here are quite different from previous reports,
which has comprehensive described and summarized the
process of cataplectic attack.
The excitability of PMC during QW and
laughter
A notable decrease in ICF was observed during QW, sug-
gesting a potential inhibition of the motor cortex in NT1
patients.20 Previous studies (Table 3) have reported
higher MT, decreased MEP amplitude, prolonged CSP
duration, and more significant SICI in drug-naive nar-
coleptic patients, which supports a coincidence conclusion
of PMC hypoexcitability in the QW.21–24 The increased
MEP amplitude during laughter identified in this study is
also consistent with the previous study; which showed
laughter caused the mean MEP area to increase by 60%
in healthy subjects.25 However, a relatively low increase in
MEP magnitude in patients also implies the latent inhibi-
tion of PMC activity during laughter in NT1.
The orexinergic projection system is highly involved in
sleep/wake transitions and reinforces behavioral wakeful-
ness, with a widespread distribution in the whole motor
control system.26 In cortex, orexinergic afferent was
reported a direct modulation in the motor cortex layer
VI-b.27 Therefore, absence of orexinergic output in NT1
may lead to a mild decrease of excitability in the PMC
during QW and laughter.
The fluctuation of PMC excitability during
cataplexy
Previously, the studies of the main mechanisms of cata-
plexy focused on the suppression of brainstem neural cir-
cuits promoting rapid eye movement (REM) sleep-like
muscle atonia, which is induced by the activations of
medial prefrontal cortex (mPFC) and amygdala.28–30 Our
study observed a fluctuation of MEP amplitude during
the cataplectic process, which indicates that PMC takes
part in the process of cataplexy attack. The significantly
increased MEP amplitude during CA2 accompanying the
voluntary motor movement, implies that the hyperex-
citability of PMC aims to resist the loss of muscle tone.
The inhibition during CA3 is presented as dramatically
decreased MEP amplitude and prolonged MEP latency,
and the latter had not been reported before. The pro-
longed MEP latency may also suggest a strong para-inhi-
bition of the whole corticospinal tract, which is consistent
with the changes that deep-tendon reflexes were abolished
during global cataplexy attacks and were partially inhib-
ited during partial cataplexy.31,32
Since the PMC is the dominating control center of the
voluntary motor movements with consciousness,5 we
hypothesize that the PMC works as a compensatory/resis-
tant mechanism in the brain during a cataplectic attack:
when the NT1 patient encounters laughter, most of the
time, cataplexy could not be triggered because of
Table 3. Main findings of the study exploring motor cortex excitability in patients with narcolepsy.
Patients CTL State
Transcranial magnetic stimulation
MCT Amp MT CSP SICI ICF Other
Current research 29 29 QW N – N N N ↓
12 10 LA N ↑1↓2 – – – –
12 – CA ↑ ↑↓3 – ↑ ↑ ↓
Rosler et al.(1994) 1 – CA – N – – – –
Oliviero et al. (2005) 13 12 QW N N ↑4 N – N SICF: N, ICI:↑
Nardone et al. (2010) 24 20 QW N – ↑ – ↑ N
Joo et al. (2010) 19 25 QW – N/↓5 N ↑ – –
Joo et al. (2011) 1 – CA – ↓ – – – –
Vijayakumari et al.(2013) 8 8 QW N – ↑ ↑ – –
CTL, controls; MCT, motor conduction time; Amp, peak-to-peak MEP amplitude; RMT, resting motor threshold; 1 mV MT, 1 mV motor threshold;
CSP, cortical silent period; SICI, short-interval intracortical inhibition; ICF, intracortical facilitation; SICF, short latency intracortical facilitation; ICI,
intracortical inhibition; QW, quiet wakefulness; CA, cataplexy; LA, laughter; N, normal; –, not evaluated.
1If compared with QW state, MEP amplitude increased in laughter without cataplexy episodes, 2but still lower than normal controls.
3MEP amplitude was fluctuant during cataplexy compared with QW level, which increased in CA1&2 stage, while notable decreased during CA3.
4Both RMT and active motor threshold (AMT) increased in this research. AMT was defined as the minimum stimulus intensity that produced a lim-
inal motor evoked response (about 200 lV in 50% of trials) during isometric contraction of the tested muscle at about 20% maximum.
5Amplitude normal in 120% RMT, decrease in 140% and 150% RMT
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increased PMC activity. If the laughter triggered an attack
successfully, it may lead into a resisting stage with even
higher PMC activity. If the PMC resisted the attack suc-
cessfully, the patient may enter recovery stage immedi-
ately. If resisting failed, the patient enters the atonic stage
and thus presents as complete cataplexy (Fig. 5). Further-
more, four stages of cataplexy may hardly be regarded as
four distinguishable phases. For example, some patients
with partial cataplexy may have only the CA1 and 2, and
recover easily. Some patients with status catapleticus have
mixed components of CA1, CA2, and CA3, with a very
difficult CA4.
During CA3, decreased MEP amplitude, prolonged
MEP latency, together with other biomarkers indicate the
inhibition of the whole motor conduction pathway. As
we know, neurons in locus coeruleus (LC), dorsal raphe
(DR) and laterodorsal tegmental nucleus (LDT) will be
inhibited by amygdala in patients with NT1 since the
absence of orexinergic excitatory inputs.33 Nevertheless,
LC、DR、LDT are part of the wake-promoting network
which helps drive cortical activation. Inhibition of these
nuclei will inhibit the excitability of the PMC. Reduction
in PMC excitability may also be due to the partial inhibi-
tion of the ascending arousal system during cataplexy;
loss of consciousness would not occur since most part of
the network is still working. In addition, cataplexy can be
regarded as an intrusion of REM sleep atonia into wake-
fulness. Spinal motor neuron, as a target of PMC, is
under a strong inhibitory input at the same time, and
sublaterodorsal nucleus (SLD) neurons play a critical role
in its generation.34 During REM sleep, SLD activates pre-
motor neurons in the medial medulla and spinal cord
that strongly inhibits motor neurons, and it falls silent
during wakefulness and NREM sleep.33–35 However, due
to orexin deficiency in patients with NT1, impropriate
activation of SLD neuron could occur during wakefulness
Figure 5. When triggered by laughter, patients with NT1 showed three conditions with varied activity of PMC. To some extent, PMC might
affect the process of cataplexy. PMC, primary motor cortex; NT1, narcolepsy type 1 patients.
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which may generate muscle atonia and accompanied by
depression of PMC.
Our findings highly confirm the evidence of neuroimag-
ing studies in narcolepsy. It was clear that there was no
evidence of structure alterations in PMC during quite
wakefulness36 in magnetic resonance imaging (MRI). Con-
sistent with increased PMC activity, the blood oxygenation
level dependent contrast signal was found to increase in
the bilaterally motor–premotor cortex and anterior cingu-
late cortex during laughter without cataplexy episodes.37
Interestingly, functional neuroimaging studies showed sig-
nificantly higher metabolism and higher perfusion in bilat-
eral pre-postcentral gyri during cataplectic attacks.29,38,39
These could very well be interpreted by hyperexcitability
of PMC during CA1 and 2, and during CA3. We speculate
that the attenuated MEP amplitude in CA3 may not be
due to the inhibited PMC neuron itself, but to a strong
para-inhibition from the brainstem and spinal cord. In
addition, patients treated with psychostimulant and/or
anticataplectic drugs also showed hypermetabolism in pre-
postcentral gyri compared with untreated patients.33
Clinically, narcolepsy symptoms, such as excess daytime
sleepiness, 24 h sleep time, and the severity of cata-
plexy40–42 were relieved over time in patients with or
without treatment. The alleviated phenomena imply the
existence of compensatory mechanisms. Thus, enhanced
PMC activity resisting the process of cataplexy might be a
useful acquisition method to alleviate the severity and fre-
quency of cataplectic attacks. On the other hand, from
the therapeutic perspective, antidepressants, especially
selective norepinephrine reuptake inhibitors (SNRIs), are
reported as the most effective drugs to alleviate cataplexy
via the adrenergic system.43 The dopaminergic system is
involved in the regulation of cataplexy via the D2-like
receptor in mouse models of narcolepsy.44 Cholinergic
systems are demonstrated to be very important in the reg-
ulation of cataplexy in animal models.45 Since close rela-
tionships were found between the PMC and these
neurotransmitter systems,46,47 the work of the PMC may
be to integrate the outputs of adrenergic, dopaminergic,
and cholinergic systems.
There are several limitations to this study. Firstly, MEP
amplitude and latency were influenced by the whole
motor conduction pathway, spinal activity, and the indi-
vidual muscle strengths, which could have an impact on
MEP results. Being aware of this, we also measured the
ICF, SICI, and CSP to confirm the excitability of the
PMC. Secondly, only some of the patients were triggered
into cataplectic attack in the test conditions, which might
cause some selective bias. Thirdly, considering the time-
consuming MEP tests and the transient cataplectic attack,
we could not complete all trials of the MEP parameters.
We selected 1 mV MT as the preferred during cataplexy.
Lastly, because of technology limitations we were not able
to record the EEG and EMG synchronously with TMS-
MEP. Because the attack of cataplexy is very complex,
ranging from complete cataplexy to mild attacks with
undetectable symptoms, it is a challenge to distinguish
the specific stages of cataplexy in each patient. In addi-
tion, other criteria including EEG, heart rate, and blood
pressure are needed for further analysis.
In conclusion, this is an important study to demonstrate
the dynamic process of cataplectic attacks and to analyze
the excitability of the PMC through TMS during each cata-
plectic stage. The four distinct stages of cataplexy reveal the
important evolution of the cataplectic process. The fluctua-
tion of the MEP amplitude and the prolonged MEP latency
during cataplexy shows that PMC and motor control path-
way participate in cataplectic attacks. And more impor-
tantly, the increased MEP amplitude during CA1 and 2
indicates that the PMC may act as a resisting regulator to
struggle against the loss of muscle tone or postural collapse
in patients with full consciousness. The activity of the PMC
may help patients avoid or alleviate cataplectic attack.
These findings broaden our knowledge about the integra-
tion and compensatory mechanism in the brain during cat-
aplectic attack in NT1 patients.
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